• Facts About ENKS:

  • Strong Revenue

  • Strong Cash Position

  • Low Float


  • Only 65M Shares Out

  • 200M Shares Authorized

  • No Insider Selling

  • 50% held by CEO


  • Deal Flow International

  • Strong Government Relations with many Countries

  • Solar Utility Scale Plant in completion stage 500MW $500M USD Cost Plus 10% with deferred revenue until transfer to the Grid and PPA Active

  • nearly 40 previous Solar PV facilities completed   with many more planned

  • NEW AWARD for the ChNPP Special Exclusion Zone Green Clean Solar Co generation Power Plant in Ukraine (in the news)

  • Awards for Hydrogen Electrolysis Plant at the ChNPP Site

  • 5G Telecom Network Consortium Management and financing Award for Ukraine State Telecom Holding


  • Patents Held in both Wattoz Holdings Inc Division* and Enerkon New Technology Holdings Corporate division in the areas of EV Fuel Cell Technology (Disruptive)  and Trademarks for Pharmaceutical Product Covid Shield PI (Tm)  pending Approvals and Trials

  • IP, Patents and Technology are funded and purchased without reliance on capital markets and privately funded by associates of the Chairman and the Company

  • Other Acquisitions Planned and other positive reorganization of the company for diversity as a Holding company with diverse market segment assets and IP for future growth and Shareholder Value


  • All previous acquisitions and project financing have been privately funded and company funds were not used

  • ENKS Nominated as a Corporate Sponsor of the new GULF MENA International Hydrogen Association

  • ENKS Will work with the GMIHA and the AREC to promote Hydrogen Transformation in the global energy space


  • ENKS Do not Promote the company shares or the Company in general  as it plans to Up List to NASDAQ soon for better Market Value representation and Liquidity as the OTC Market may not reflect the true value of the company and may attract Short positions from speculators from time to time

  • ENKS Plans to hire a professional IR Firm soon to expose the company to the wider public and Markets as we have not advertised over the 3 previous years at any meaningful level therefore the company is generally unknown to many in the markets and public in particular due to the fact that 90% of its operations are in Africa - Eastern Europe and other countries and no meaningful operations in the United states - while there are plans to take advantage of the new legislation in California for Solar Implementation in the residential space and other opportunities in the United States during the coming year

  • Due to Covid we continue to work in the USA Remotely with meetings as needed at official office or other facilities

  • New offices in New York are listed in our contact page


  • Follow this page Often for Updates as we will strive to post material changes facts and news items - photos and documents or other useful information for our Shareholders and/or the Public to review  - and possibly add a chat option or blog for real time communication between active shareholders or interested Investors


ENKS Patents, Trademarks Links to Government Search Database for reference:

  • United States Patent and Trademark office for the Trademark "Covid Shield as owned by ENKS New Technologies Holding


  • Patent for Al Ox Fuel Cell Disruptive Technology owned by ENKS New Technologies Holdings Inc Corporate Division


USPTO Provisional Patent #62960410

  • Wattoz Holdings Inc.

New Electroshock System for Police Prisoner Control (New Taser Type Non Lethal  Wireless Weapon System

US patent application no. US2018/106577 A1 discloses a wireless electroshock weapon configured to launch a wireless projectile toward a subject so as to deliver a shock to the subject

(it is noted that while we declined purchase of Equity in the Patent Holder we maintain rights pursuant to our Joint Production and Marketing agreement as tied to the jointly owned Wattoz Holdings Inc Corporate Division of ENKS)


ENKS has purchased 100% Shares in a Sub Sales Agent who holds a co op sales agreement with KrowdX signed as  their memorandum of understanding together, for co sales, of the patented device owned by GLC Canada  a Patented OEM Medical Device for Rapid Testing of COVID19 using Graphene Biosensor Technology - Patented By Graphene Leaders - Canada with Marketing Rights Held by KrowdX in Canada and co sales memorandum of understanding with our Acquisition - Coviklear International Holdings Ltd. (UK) a co-op Sales agreement  (Non-Exclusive) .


The purchase of 100% Coviklear shares  add to shareholder value and upon  approval of HC/FDA and WHO will produce significant revenue for the company's.

USPTO Provisional  Patent

63/040,511 (Printed Graphene Biosensor Graphene Leaders Canada)

(This Patent is NOT owned by ENKS

Coviklear Intl Holdings Ltd (UK) is now a wholly owned corporate division of ENKS Congratulations to another

We look forward to Closing the Funding for KrowdX Order fulfillment support and Approval support agreements in the coming week and look forward to this supporting GLC Canada aspiration and all of the companies aspirations to bring their wonderful product to the public saving and protecting lives !

Together we are STRONG.

Victory for the ENKS ARMY !


ENERKON INTERNATIONAL is inviting you to a scheduled Zoom meeting a Shareholder Call open to the Public .


Topic: ENERKON Solar Internationals Shareholder Call open to the Public


Zoom Meeting Time: Mar 15, 2021 02:00 PM Eastern Time Thursday (US and Canada)

ENKS (ENERKON) Shareholder Zoom meeting: Time: Mar 15, 2021 02:00 PM Eastern Time https://us02web.zoom.us/j/87210479192?pwd=SHB5YkZGV2h2cDFmVlhXaG4xNjM5QT09 Meeting ID: 872 1047 9192 Pass-code: 778818 One tap mobile +13126266799,,87210479192#,,,,*778818# US (Chicago) +16465588656,,87210479192#,,,,*778818# US (New York)